Catalyst Pharmaceutical
CPRX
CPRX
268 hedge funds and large institutions have $1.53B invested in Catalyst Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 107 increasing their positions, 70 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
268
Holders Change
+9
Holders Change %
+3.47%
% of All Funds
3.89%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
52
Increased
107
Reduced
70
Closed
40
Calls
$1.78M
Puts
$2.13M
Net Calls
-$349K
Net Calls Change
-$2.53M
Top Buyers
| 1 |
BlackRock
New York
|
$283M |
| 2 |
Marshall Wace
London,
United Kingdom
|
$26.8M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
$43.4M |
| 4 |
State Street
Boston,
Massachusetts
|
$130M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$127M |
